Cite
810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure.
MLA
Yusuf, Salim, et al. “810-1 Impact of the Angiotensin-Receptor Blocker Candesartan in Preventing Diabetes in Patients with Heart Failure.” Journal of the American College of Cardiology (JACC), vol. 43, Mar. 2004, p. A473. EBSCOhost, https://doi.org/10.1016/S0735-1097(04)92003-7.
APA
Yusuf, S., Ostergren, J. B., Gerstein, H., Pfeffer, M. A., Swedberg, K., Granger, C. B., & McMurray, J. J. . (2004). 810-1 Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure. Journal of the American College of Cardiology (JACC), 43, A473. https://doi.org/10.1016/S0735-1097(04)92003-7
Chicago
Yusuf, Salim, Jan B Ostergren, Hertzel Gerstein, Marc A Pfeffer, Karl Swedberg, Chris B Granger, and John J.V McMurray. 2004. “810-1 Impact of the Angiotensin-Receptor Blocker Candesartan in Preventing Diabetes in Patients with Heart Failure.” Journal of the American College of Cardiology (JACC) 43 (March): A473. doi:10.1016/S0735-1097(04)92003-7.